Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M L Teo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|May 30, 2018
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in AsiaHerbert H Loong, Victoria M Raymond, Yukimasa Shiotsu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceMichael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survivalEdwin P Hui, Anthony T C Chan, Francesco Pezzella, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment timeAnne W M Lee, Dora L W Kwong, Sing Fai Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experienceAnne W M Lee, W M Sze, Joseph S K Au, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patientsMichael K M Kam, Sing-Fai Leung, Benny Zee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNAAnthony T C Chan, Brigette B Y Ma, Y M Dennis Lo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2006
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)Peter M L Teo, Sing Fai Leung, Stewart Y Tung, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|May 30, 2018
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in AsiaHerbert H Loong, Victoria M Raymond, Yukimasa Shiotsu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceMichael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survivalEdwin P Hui, Anthony T C Chan, Francesco Pezzella, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment timeAnne W M Lee, Dora L W Kwong, Sing Fai Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experienceAnne W M Lee, W M Sze, Joseph S K Au, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patientsMichael K M Kam, Sing-Fai Leung, Benny Zee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNAAnthony T C Chan, Brigette B Y Ma, Y M Dennis Lo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2006
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)Peter M L Teo, Sing Fai Leung, Stewart Y Tung, et al.
Pageof 3